BlueCrest Capital Management’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,010	Closed	-$459K	–	253
2023 Q1	$459K	Buy	+11,010	New	+$459K	0.02%	160